Covered recipient · General Payments record
ANJALI A PATHAK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$20,826.43
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,122.50 | 1 |
| Food and Beverage | $222.84 | 3 |
| Travel and Lodging | $64.89 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $4,199.86 | 4 |
| Otsuka America Pharmaceutical, Inc. | $114.75 | 1 |
| ABBVIE INC. | $95.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (6)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $95.62 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998102141 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $4,122.50 | 03/07/2023 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | 1034475799 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $24.89 | 03/14/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1034475793 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $40.00 | 03/14/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1034475805 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $12.47 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034475811 | CMS |
| Otsuka America Pharmaceutical, Inc. | $114.75 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014681871 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.